Loading…
YD Bio Ltd is projected to decline to $1.96 by 2027, a -10% move from its current price of $2.17. YDES is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 8/3/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Aug 4 | $2.05 | $2.17 | $2.30 | +0.01% |
| Aug 5 | $2.00 | $2.17 | $2.36 | +0.02% |
| Aug 6 | $1.96 | $2.17 | $2.40 | +0.03% |
| Aug 7 | $1.93 | $2.17 | $2.44 | +0.04% |
| Aug 8 | $1.90 | $2.17 | $2.48 | +0.05% |
| Aug 9 | $1.88 | $2.17 | $2.51 | +0.06% |
| Aug 10 | $1.86 | $2.17 | $2.54 | +0.07% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $1.86 | $2.17 | $2.54 | +0.07% |
| Week 2 | $1.74 | $2.17 | $2.71 | +0.15% |
| Week 3 | $1.66 | $2.17 | $2.85 | +0.22% |
| Week 4 | $1.59 | $2.18 | $2.97 | +0.30% |
| Week 5 | $1.54 | $2.18 | $3.09 | +0.37% |
| Week 6 | $1.49 | $2.18 | $3.19 | +0.44% |
| Week 7 | $1.44 | $2.18 | $3.30 | +0.52% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
YD Bio Ltd is a biopharmaceutical company focused on blood-based cancer detection.
It develops stem cell- and exosome-based therapeutics to transform treatment of a spectrum of diseases with unmet medical needs.
The company is based in Taipei, Taiwan, and operates in the Healthcare sector.
YD Bio Ltd (YDES) is a healthcare asset with current price $2.24 and a market cap of $158.66M, ranking 3754.
The 30-year forecast sketches a path of gradual upside, with 2026 avg $2.24, 2030 avg $3.30, and 2050 avg $7.62.
The forecast also lays out min and max values across years, for example 2030 min $1.73 and max $6.44, and 2050 min $3.43 and max $17.53.
ROIs vary by year, with 2030 ROI 47.5%, 2050 ROI 240.2%.
A major floor 35.6% below — a decisive break under it would weaken the trend.
The nearest floor, 12.4% below — buyers have tended to step in here.
The nearest ceiling, 28.6% above — a clean break opens room to run.
A major ceiling 273.3% above — clearing it would confirm fresh momentum.
Key YDES support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of YDES market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $2.25 | Sell | $2.22 | Sell |
| MA 10 | $2.23 | Sell | $2.23 | Sell |
| MA 20 | $2.22 | Sell | $2.30 | Sell |
| MA 50 | $2.75 | Sell | $2.98 | Sell |
| MA 100 | $4.41 | Sell | $4.54 | Sell |
| MA 200 | $8.07 | Sell | $7.05 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.12 | Neutral |
| Stoch RSI (14) | 49.18 | Neutral |
| CCI (20) | -33.28 | Neutral |
| Williams %R (14) | -69.05 | Info |
| MACD (12,26,9) | 0.05 | Buy |
| ROC (12) | -4.41 | Sell |
| Bollinger %B (20,2) | 0.40 | Neutral |
| Stochastic %K (14) | 30.95 | Neutral |
| TRIX (15) | -1.10 | Sell |
| Awesome (5,34) | -0.12 | Sell |
| Ultimate (7,14,28) | 46.97 | Neutral |
| Momentum (10) | -0.28 | Sell |
| Aroon Osc (25) | 36.00 | Buy |
| Hull MA (9) | 2.24 | Sell |
| ADX (14) | 20.58 | Sell |
| ATR (14) | 0.12 | Info |
The 30-day technical picture is NEUTRAL, with RSI14 at 40.
SMA50 is $3.09 and SMA200 is $8.55.
Support is $1.90 and resistance is $3.39. The 30-day range spans $1.44 to $3.49.
Annualized volatility is 100%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $1.90 | $2.17 | $2.73 | 0% | Neutral | |
| $1.33 | $1.96 | $3.13 | -10% | Neutral | |
| $1.36 | $2.20 | $3.82 | +2% | Neutral | |
| $1.47 | $2.57 | $4.74 | +18% | Neutral | |
| $1.69 | $3.19 | $6.18 | +47% | Bullish | |
| $1.40 | $2.84 | $5.74 | +31% | Bullish | |
| $1.15 | $2.50 | $5.24 | +15% | Neutral | |
| $1.27 | $2.81 | $6.10 | +30% | Bullish | |
| $1.08 | $2.40 | $5.37 | +11% | Neutral | |
| $1.23 | $2.73 | $6.27 | +26% | Bullish | |
| $1.45 | $3.22 | $7.41 | +49% | Bullish | |
| $3.30 | $7.33 | $16.85 | +238% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| August 2026 | $1.90 | $2.17 | $2.58 | +0.00% |
| September 2026 | $1.66 | $2.07 | $2.70 | -4.76% |
| October 2026 | $1.73 | $2.19 | $2.94 | +6.02% |
| November 2026 | $1.63 | $2.10 | $2.89 | -4.02% |
| December 2026 | $1.50 | $1.95 | $2.73 | -7.08% |
Click any year to see its month-by-month YDES forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
YD Bio Ltd's 2026 outlook centres on $2.17, within a $1.90 to $2.73 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, YDES could reach as high as $3.13, with a base case around $1.96 and support toward $1.33 — roughly -10% from $2.17. A consolidation phase looks the most probable path here.
Expect YDES to range from $1.36 to $3.82 through 2028. The $2.20 average target implies a +2% move from current prices. That is up +13% on the projected 2027 average. Price action looks broadly range-bound.
The YDES price prediction for 2029 points to an average of $2.57 (low $1.47, high $4.74) — a potential gain of +18% on today's $2.17. A consolidation phase looks the most probable path here.
In 2030, YDES is projected to trade between $1.69 and $6.18, averaging $3.19 — a potential gain of +47% from today's $2.17. That is up +24% on the projected 2029 average. Momentum favours further upside here.
YD Bio Ltd's 2031 outlook centres on $2.84, within a $1.40 to $5.74 range. That is -11% versus the projected 2030 average. That marks a +31% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, YDES could reach as high as $5.24, with a base case around $2.50 and support toward $1.15 — roughly +15% from $2.17. Price action looks broadly range-bound.
Expect YDES to range from $1.27 to $6.10 through 2033. The $2.81 average target implies a +30% move from current prices. That is up +13% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The YDES price prediction for 2034 points to an average of $2.40 (low $1.08, high $5.37) — a potential gain of +11% on today's $2.17. Price action looks broadly range-bound.
In 2035, YDES is projected to trade between $1.23 and $6.27, averaging $2.73 — a potential gain of +26% from today's $2.17. That is up +14% on the projected 2034 average. Buyers look set to stay in control over this stretch.
YD Bio Ltd's 2040 outlook centres on $3.22, within a $1.45 to $7.41 range. That is up +18% on the projected 2035 average. That marks a +49% change versus current levels. Momentum favours further upside here.
By 2050, YDES could reach as high as $16.85, with a base case around $7.33 and support toward $3.30 — roughly +238% from $2.17. Buyers look set to stay in control over this stretch.
Investing $1,000 in YDES today (≈ 460.829493 YDES) could be worth
$3,375.99
+$2,375.99 (+238%) by 2050 · US Dollar
Based on the average projected YDES price of $7.33 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in YDESwould be worth at today's price.
$1,000 invested in YDES on Aug 26, 2025 (≈ 74.850301 YDES) would be worth
$162.43
-$837.57 (-83.8%) today · 0.16× · US Dollar
Based on a YDES entry price of $13.36 vs. today's $2.17.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $2.24 | $968.75 | -3.1% |
| 1 month ago | $2.31 | $939.39 | -6.1% |
| 3 months ago | $4.8 | $452.08 | -54.8% |
| 6 months ago | $11.47 | $189.19 | -81.1% |
| All time ago | $13.36 | $162.43 | -83.8% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our YDES forecast.
Our base-case forecast reaches $4.30 around 2050.
Implied market cap at $4.30: $304.57M
Looking at the multi-year forecast, 2030 shows an average price of $3.30 with a 47.5% ROI and bullish sentiment. 2031 presents an average of $2.88 with a 28.6% ROI, while 2032 shows $2.60 with 15.9%. 2033 yields $2.94 on average with 31.4% ROI and 2034 projects $2.41 with 7.7%.
2035 carries $2.84 on average with 26.8% ROI, and the trajectory continues toward 2040 with an average of $3.26 and 45.4% ROI, followed by 2050 at $7.62 on average with 240.2% ROI.
These figures illustrate a long-term bullish potential into the 2030s and beyond, with notable upside by 2050, but they are estimates, not guarantees, and depend on future market and company outcomes.
Tap a question to reveal the answer.
Avg price $3.30, min $1.73, max $6.44; ROI 47.5%; sentiment BULLISH.
Forecasts show bullish sentiment in 2030, 2031, 2033, 2040, and 2050 with ROIs such as 47.5% in 2030 and 240.2% in 2050; these are estimates and not guarantees.
2033 max is $6.42; min $1.32; avg $2.94, so reaching $5 is possible within the forecast's max, but not guaranteed.
Current price $2.24 and market cap $158.66M.
Sentiment NEUTRAL; RSI14 40; SMA50 $3.09; SMA200 $8.55; 30-day range $1.44-$3.49; support $1.90; resistance $3.39; annualized volatility 100%.
YD Bio Ltd Community Discussion
0Share your YD Bio Ltd price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.